NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026

NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026

  • April 2018 •
  • 88 pages •
  • Report ID: 5373306 •
  • Format: PDF
KEY FINDINGS
The North America immunohistochemistry market is growing significantly at 8.01% of CAGR from 2018 to 2026. The immunohistochemistry market is developing majorly due to the growing prevalence of autoimmune disease especially in the young girls along with women of all age groups up to 64 years.

MARKET INSIGHTS
North America holds the highest market share in the global immunohistochemistry market.This growth of the market is attributed to the rising healthcare cost in the region.

The major countries in the North America region are the United States and Canada.The United States is the highest contributor to the North America immunohistochemistry market.

Increasing cases of cancer in the country is one of the major reasons for the growth of the market in the country.In Canada, common types of cancer are lung, breast, colorectal and prostate.

This upsurge is advancing the demand for IMS in the region.

COMPETITIVE INSIGHTS
The leading players in the market are Merck Millipore, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Siemens Ag Healthcare, Danaher Corporation, Cell Signaling Technology Inc., Agilent Technologies Inc., Histologix, Abbott Laboratories, F. Hoffmann-La Roche Ag, Abcam Plc, Biogenex, Perkinelmer, Inc., and Bio Sb.